Zone Frontier Inc.
ZONE NYSE Specialty Cleaning, Polishing And Sanitation Preparations Financials FY2024βFY2026
What Zone Frontier Inc. does
No business description yet.
- Legal name
- Zone Frontier Inc.
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K Β· Sep 28, 2026
- Accession Β· CIK
- 0001213900-26-104157
0001956741
Revenue and margins
Zone Frontier Inc. had $3.4M of revenue in fiscal 2026, up 64.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$18.2M in fiscal 2026, β534.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Zone Frontier Inc. returned β to shareholders in fiscal 2026. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Zone Frontier Inc. can carry it.
| Fiscal year end | FY24 | FY25 | FY26 |
|---|---|---|---|
| Cash and short-term investments | $2.0M | $1.5M | $15.4M |
| Interest coverage | β5.8x | β17.9x | β |
| Current ratio | 2.1x | 1.3x | 21.2x |
| Quick ratio | 1.7x | 0.9x | 20.2x |
| Total assets | $7.5M | $8.5M | $52.5M |
| Total liabilities | $3.7M | $7.0M | $1.0M |
| Shareholders' equity | $3.7M | $1.5M | $51.5M |
| Net debt (β = net cash) | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | 2 / 7 | 2 / 7 |
| Accruals ratio | β9.8% | β55.2% | β511.7% |
| Altman Z'' | β2.39 | β9.51 | 37.49 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY24 | FY25 | FY26 |
|---|---|---|---|
| Income statement | |||
| Revenue | $1.6M | $2.1M | $3.4M |
| Gross profit | $0.8M | $1.0M | $1.3M |
| Operating income | β$1.9M | β$6.4M | β$58.0M |
| Interest expense | $0.3M | $0.4M | β$0.1M |
| Net income | β$2.3M | β$6.7M | β$174M |
| Cash flow | |||
| Cash from operations | β$1.5M | β$2.3M | β$18.2M |
| Capital expenditure | $0.0M | $0.0M | $0.0M |
| Free cash flow | β$1.6M | β$2.4M | β$18.2M |
| Depreciation and amortization | $0.2M | $0.2M | $0.3M |
| Stock-based compensation | $0.7M | $3.2M | $9.2M |
| Acquisitions | β | $0.6M | β |
| Balance sheet | |||
| Cash and short-term investments | $2.0M | $1.5M | $15.4M |
| Current assets | $3.2M | $3.8M | $18.7M |
| Current liabilities | $1.5M | $2.8M | $0.9M |
| Inventory | $0.7M | $1.3M | $0.9M |
| Property and equipment, net | $0.0M | $0.0M | $0.1M |
| Goodwill | $2.2M | $2.2M | $0.0M |
| Intangible assets | $1.5M | $2.0M | $0.0M |
| Total assets | $7.5M | $8.5M | $52.5M |
| Total liabilities | $3.7M | $7.0M | $1.0M |
| Shareholders' equity | $3.7M | $1.5M | $51.5M |
| Margins | |||
| Gross margin | 49.6% | 47.6% | 37.8% |
| Operating margin | β121.3% | β308.1% | β1,702.1% |
| EBITDA margin | β111.6% | β298.3% | β1,694.2% |
| Net margin | β142.2% | β325.3% | β5,112.8% |
| FCF margin | β97.1% | β114.3% | β534.1% |
| Returns | |||
| Return on capital employed | β32.6% | β113.6% | β112.3% |
| Return on equity | β61.1% | β259.2% | β657.5% |
| Return on assets | β30.5% | β84.6% | β571.3% |
| Return on tangible equity | β19,501.7% | β | β338.1% |
| Growth | |||
| Revenue growth | β | 29.1% | 64.3% |
| Financial health | |||
| Interest coverage | β5.8x | β17.9x | β |
| Current ratio | 2.1x | 1.3x | 21.2x |
| Quick ratio | 1.7x | 0.9x | 20.2x |
| Capital allocation | |||
| Capex / revenue | 0.6% | 1.6% | 1.1% |
| Stock comp / revenue | 41.8% | 154.5% | 270.9% |
| Quality scores | |||
| Piotroski F-score | β | 2.0 | 2.0 |
| Altman Z'' | β2.4 | β9.5 | 37.5 |
| Accruals ratio | β9.8% | β55.2% | β511.7% |
Source: SEC EDGAR XBRL filings (CIK 0001956741). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.